Compare AP & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AP | IXHL |
|---|---|---|
| Founded | 1929 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Fluid Controls | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.5M | 49.1M |
| IPO Year | N/A | N/A |
| Metric | AP | IXHL |
|---|---|---|
| Price | $2.74 | $0.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 193.2K | ★ 10.4M |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $426,314,000.00 | $12,000.00 |
| Revenue This Year | N/A | $1,188.37 |
| Revenue Next Year | N/A | $3,569.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.20 | N/A |
| 52 Week Low | $1.75 | $0.08 |
| 52 Week High | $3.99 | $2.25 |
| Indicator | AP | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 62.70 | 57.52 |
| Support Level | $2.46 | $0.35 |
| Resistance Level | $2.99 | $0.37 |
| Average True Range (ATR) | 0.30 | 0.02 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 77.83 | 96.49 |
Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.